A featured article on the Italian biotech market has been published on GEN (Genetic Engineering&Biotechnology News).
There are several main obstacles that prevent the Italian biotechnology industry from taking off. These hurdles are complex and rooted in cultural, as well as market infrastructural considerations. The “Life Science Innovation—From Vision to Commercialization”, bootcamp held recently in Florence and organized together with Versaggi Biocommunications e The International Institute for Biotechnology Entrepreneurship, highlighted the realities facing Italian executives and sought to provide them with the fundamental strategies and skills to form, launch, and operate a life science company.
The article titled “Italian Biotech Revamps Old-World Mindset. Casting Off  Traditional Business Customs Expected to Push the Industry Forward” provides insights about the opportunities open to the Italian biotech and life science companies and start-ups. The article has been jointly written by Alberto Onetti (Director of CrESIT), Charles Versaggi (president of Versaggi Biocommunications) e Bruce Mackler, FDA legal and regulatory expert. You can read it at the following link:  http://www.genengnews.com/articles/chitem.aspx?aid=2994